Induction therapy with PD-1 antibody combined with platinum-based doublet chemotherapy for locally-advanced non-small cell lung cancer: A randomised controlled, open-label, phase 2 trial

被引：0
|
作者：
Wang, Suyu [1 ]
Zhang, Peng [1 ]
机构：
[1] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Thorac Surg, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8044
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Perioperative PD-1 antibody tislelizumab plus chemotherapy for locally advanced gastro-oesophageal junction cancer: A prospective, nonrandomized, open-label, phase II trial
    Nie, Run-Cong
    Ding, Ya
    Yuan, Shu-Qiang
    Li, Yuan-fang
    Wang, Wei
    Chen, Yongming
    Cai, Muyan
    Sun, Xiao-wei
    Weng, Desheng
    Li, Dandan
    Zhao, Jingjing
    Chen, Xiaojiang
    Guan, Yuanxiang
    Ma, Luo
    Qiu, Haibo
    Zhou, Zhi-wei
    Zhang, Xiao-Shi
    Chen, Ying-bo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] A slow disengagement from platinum-based chemotherapy for patients with advanced non-small cell lung cancer
    Ballas, MS
    Dennis, PA
    CANCER BIOLOGY & THERAPY, 2005, 4 (12) : 1316 - 1317
  • [33] Is the platinum-based chemotherapy necessary for elderly patients with advanced non-small cell lung cancer (NSCLC)?
    Daga, H.
    Takeda, K.
    Kiyota, H.
    Tokunaga, S.
    Nanjo, S.
    Sumitani, M.
    Shoji, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer
    Patel, Shetal A.
    Gerber, David E.
    Deal, Allison
    Douglas, Kathe
    Pecot, Chad V.
    Lee, Carrie
    Schiller, Joan
    Dhruva, Nirav
    Weiss, Jared
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [35] Phase II pharmacodynamic trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients previously treated with platinum-based chemotherapy
    Felip, E
    Rojo, F
    Heller, A
    Foernzler, D
    Majo, J
    Klughammer, B
    Ramos, J
    Maacke, H
    Brennscheidt, U
    Baselga, J
    LUNG CANCER, 2005, 49 : S369 - S369
  • [36] A phase II, open-label trial of bortezomib (VELCADE®) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer
    E. Kontopodis
    A. Kotsakis
    N. Kentepozidis
    K. Syrigos
    N. Ziras
    M. Moutsos
    G. Filippa
    A. Mala
    L. Vamvakas
    D. Mavroudis
    V. Georgoulias
    S. Agelaki
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 949 - 956
  • [37] A phase II, open-label trial of bortezomib (VELCADE®) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer
    Kontopodis, E.
    Kotsakis, A.
    Kentepozidis, N.
    Syrigos, K.
    Ziras, N.
    Moutsos, M.
    Filippa, G.
    Mala, A.
    Vamvakas, L.
    Mavroudis, D.
    Georgoulias, V.
    Agelaki, S.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (05) : 949 - 956
  • [38] Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
    Vansteenkiste, J.
    Barlesi, F.
    Waller, C. F.
    Bennouna, J.
    Gridelli, C.
    Goekkurt, E.
    Verhoeven, D.
    Szczesna, A.
    Feurer, M.
    Milanowski, J.
    Germonpre, P.
    Lena, H.
    Atanackovic, D.
    Krzakowski, M.
    Hicking, C.
    Straub, J.
    Picard, M.
    Schuette, W.
    O'Byrne, K.
    ANNALS OF ONCOLOGY, 2015, 26 (08) : 1734 - 1740
  • [39] Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet
    Kozlowska, Emilia
    Suwinski, Rafal
    Giglok, Monika
    Swierniak, Andrzej
    Kimmel, Marek
    PLOS COMPUTATIONAL BIOLOGY, 2020, 16 (10)
  • [40] Endostatin Combined with Platinum-Based Chemo-radiotherapy for Advanced Non-small Cell Lung Cancer
    Jiang, Xuan
    Guan, Wei
    Li, Mengxia
    Liang, Wei
    Qing, Yi
    Dai, Nan
    Zhang, Shiheng
    Deng, Yi
    Meng, Hao
    Yang, Yuxin
    Zhong, Zhaoyang
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 71 (02) : 571 - 577
12345